Form 4: Phreesia Executive Linetsky Receives 66,000 RSU Grant

David Linetsky, President of Network Solutions at Phreesia, Inc., was granted 66,000 Restricted Stock Units, aligning his incentives with long-term company performance.

Summary

• David Linetsky, President, Network Solutions at Phreesia, Inc. (PHR), acquired 66,000 Restricted Stock Units (RSUs).
• The transaction date for the RSU acquisition was December 5, 2025.
• Each RSU represents the contingent right to receive one share of Phreesia's common stock.
• The RSUs were granted at a price of $0.
• Following this transaction, David Linetsky beneficially owns 237,829 shares directly and 9,883 shares indirectly through his spouse.
• The RSUs vest over four years: 10% on December 5, 2026, 20% on December 5, 2027, 30% on December 5, 2028, and 40% on December 5, 2029.
• Vesting is contingent upon Mr. Linetsky's continued service to Phreesia through each vesting date.
• The grant was approved by the Compensation Committee of the Board of Directors on October 1, 2025.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a key executive is generally a positive event, indicating management retention and alignment with long-term company performance. It's a routine compensation action, not a major catalyst, hence a moderately positive score.

Positives

• The grant of 66,000 Restricted Stock Units (RSUs) to a key executive, David Linetsky, aligns management's interests with long-term shareholder value.
• The multi-year vesting schedule incentivizes the executive's continued service and commitment to the company's future performance.
• The Compensation Committee's approval indicates a structured approach to executive compensation.

Negatives

• No direct negatives are identified in this routine insider transaction report.

Risks

• The vesting of the Restricted Stock Units is subject to the reporting person's continued service to the Issuer through each vesting date, meaning the executive could forfeit unvested shares if employment ceases.

Future Outlook

The multi-year vesting schedule for the Restricted Stock Units indicates a long-term commitment from a key executive, David Linetsky, to Phreesia's future performance and strategic objectives, with full vesting extending through December 2029.

Industry Context

The grant of Restricted Stock Units (RSUs) to a senior executive is a common practice in the technology and healthcare IT sectors, including companies like Phreesia. This form of equity compensation is widely used to attract, retain, and incentivize key talent by aligning their financial interests with the long-term growth and success of the company, similar to practices seen at competitors and peers in the digital health space.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a form of executive compensation is a standard practice across publicly traded companies, particularly in the technology and healthcare sectors, including peers like Teladoc Health (TDOC) or Veeva Systems (VEEV).
• Multi-year vesting schedules, such as the four-year schedule detailed for Mr. Linetsky's grant, are typical for RSUs, designed to promote long-term retention and performance alignment, consistent with industry benchmarks.
• The approval of such grants by a Compensation Committee of the Board of Directors is a standard corporate governance practice, ensuring oversight and alignment with shareholder interests.

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU grant aligns the executive's long-term financial interests with shareholder value creation, potentially leading to improved company performance and retention of key talent.
• Employees: May signal stability in leadership and a commitment to long-term growth, potentially boosting morale.

Next Steps

• Vesting of 10% of RSUs on December 5, 2026.
• Vesting of 20% of RSUs on December 5, 2027.
• Vesting of 30% of RSUs on December 5, 2028.
• Vesting of 40% of RSUs on December 5, 2029.

Key Dates

Keywords

Phreesia, PHR, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Stock Grant, David Linetsky, Corporate Governance